Coronavirus (COVID-19): impact on the conduct of clinical trials under the Medical Research Involving Human Subjects Act (WMO)

The information below is valid during the COVID-19 pandemic until the situation is normalised and this is stated on the website ...

Publication | 12-05-2020

Instruction to register the supply of alternative medical devices

A manufacturer, authorised representative, distributor, or importer can register the supply of an alternative medical device with ...

Publication | 10-04-2020

IGJ position as a result of the ANSM decision relating to breast implants

With this letter, the Health and Youth Care Inspectorate [Inspectie Gezondheidszorg en Jeugd] (IGJ) informs the Minister for ...

Position statement | 17-05-2019

Domestic test facilities

Publication | 19-03-2019

Cross border pharmacies

In the Netherlands, some pharmacies provide prescription medicines to people who live in other EU member states. Those pharmacies ...

Publication | 12-12-2018

IGJ position on textured and smooth breast implants and BIA-ALCL

At the beginning of this year, scientific research was published that shows that there is a link between a certain type of cancer ...

Position statement | 26-11-2018

Good care in care networks - Position Paper on Integrated Care

In the past few years, the Health and Youth Care Inspectorate (IGJ) has laid the foundation for supervising care networks for ...

Publication | 16-08-2018

Results of the Pharmacovigilance Risk-Based Survey in the Netherlands

Report | 04-07-2018

Frequently asked questions about sterilisation product Essure

Publication | 28-06-2018

Supply of unregistered pharmaceutical products: FAQs

Publication | 19-06-2018